Skip to main content

Cervarix Disease Interactions

There are 3 disease interactions with Cervarix (human papillomavirus vaccine).

Major

Vaccination (applies to Cervarix) infections

Major Potential Hazard, High plausibility. Applicable conditions: Fever, Infection - Bacterial/Fungal/Protozoal/Viral

Ideally, vaccination should occur when an individual is healthy, thus minimizing the risk of an adverse host reaction and/or vaccine failure. However, a current or recent infection does not necessarily preclude the use of vaccines, depending on the severity of the patient's symptoms and their etiology. Superficial infections and minor acute illnesses such as a mild upper respiratory infection with or without low-grade fever do not contraindicate immunization, particularly if prompt administration of a vaccine is deemed necessary or beneficial. In fact, when vaccines are administered during the course of a minor illness, the risk of adverse events is not increased, and serum antibody response is not often diminished. On the other hand, if fever or symptoms suggest a moderate or severe illness, it is usually appropriate to withhold vaccination until the patient has recovered. In addition to the potential risks already mentioned, evolving signs and symptoms of the illness can sometimes confound the diagnosis of a vaccine reaction if it develops. In the presence of any infection, the decision to administer or withhold/defer immunization should take into consideration the benefits versus the risks to an individual patient.

References

  1. "Product Information. Typhim VI (typhoid vaccine, inactivated)." Apothecon Inc (2022):
  2. "Product Information. Varivax (varicella virus vaccine)." Merck & Co., Inc (2022):
  3. "Product Information. Pneumovax 23 (pneumococcal 23-polyvalent vaccine)." Merck & Co., Inc (2022):
  4. "Product Information. Mumpsvax (mumps virus vaccine)." Merck & Co., Inc (2022):
  5. "Product Information. Meruvax II (rubella virus vaccine)." Merck & Co., Inc (2022):
  6. "Product Information. Attenuvax (measles virus vaccine)." Merck & Co., Inc (2022):
  7. "Product Information. Orimune (poliovirus vaccine, live, trivalent)." Lederle Laboratories (2022):
  8. "Product Information. YF-Vax (yellow fever vaccine)." sanofi pasteur PROD (2001):
  9. "Product Information. Omnihib (haemophilus b conjugate vaccine (obsolete))." SmithKline Beecham PROD
  10. "Product Information. Menomune A/C/Y/W-135 (meningococcal polysaccharide vaccine)." Connaught Laboratories Inc
  11. "Product Information. Plague Vaccine (plague vaccine)." Greer Laboratories Inc PROD (2001):
  12. American Academy of Pediatrics. Committee on Infectious Diseases; Peter G, ed. "Red BooK: Report of the Committee on Infectious Diseases." Grove Village, IL: American Academy of Pediatrics (1997):
  13. "Product Information. Cholera Vaccine (cholera vaccine)." Wyeth-Ayerst Laboratories PROD
  14. "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham PROD
  15. "Product Information. Engerix-B (HepB) (hepatitis B adult vaccine)." Apothecon Inc (2022):
  16. "Product Information. Zostavax (zoster vaccine live)." Merck & Co., Inc (2006):
  17. "Product Information. Gardasil (human papillomavirus vaccine)." Merck & Co., Inc (2006):
  18. "Product Information. Gardasil 9 (human papillomavirus vaccine)." Merck & Co., Inc (2016):
View all 18 references
Moderate

Human papillomavirus (applies to Cervarix) syncope

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Dehydration, Hypotension

The administration of human papillomavirus vaccine has been associated with syncope, sometimes resulting in falling with injury. The syncope sometimes is associated with tonic-clonic movements and other seizure-like activity. Caution is recommended when administering the vaccine to individuals susceptible to syncope. Observation for 15 minutes is recommended after its administration.

References

  1. "Product Information. Gardasil (human papillomavirus vaccine)." Merck & Co., Inc (2006):
  2. "Product Information. Gardasil 9 (human papillomavirus vaccine)." Merck & Co., Inc (2016):
Moderate

Vaccines (inactivated)/toxoids (applies to Cervarix) immunodeficiency

Moderate Potential Hazard, High plausibility.

The expected serum antibody responses may not be obtained when vaccines and/or toxoids are administered to patients with primary or acquired immunodeficiency, including those with severe combined immunodeficiency, hypogammaglobulinemia or agammaglobulinemia, HIV infection, altered immune states (due to diseases such as leukemia, lymphoma, or generalized malignancy), or immunosuppression due to drug or other treatments (e.g., corticosteroids, alkylating agents, antimetabolites, or radiation).

References

  1. "Product Information. Tetanus Toxoid Adsorbed (tetanus vaccine)." Aventis Pharmaceuticals PROD (2001):
  2. "Product Information. Typhim VI (typhoid vaccine, inactivated)." Apothecon Inc (2022):
  3. "Product Information. Pneumovax 23 (pneumococcal 23-polyvalent vaccine)." Merck & Co., Inc (2022):
  4. "Product Information. Fluzone (influenza virus vaccine, inactivated)." Connaught Laboratories Inc
  5. "Product Information. Omnihib (haemophilus b conjugate vaccine (obsolete))." SmithKline Beecham PROD
  6. "Product Information. Menomune A/C/Y/W-135 (meningococcal polysaccharide vaccine)." Connaught Laboratories Inc
  7. "Product Information. Plague Vaccine (plague vaccine)." Greer Laboratories Inc PROD (2001):
  8. American Academy of Pediatrics. Committee on Infectious Diseases; Peter G, ed. "Red BooK: Report of the Committee on Infectious Diseases." Grove Village, IL: American Academy of Pediatrics (1997):
  9. "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham PROD
  10. "Product Information. Engerix-B (HepB) (hepatitis B adult vaccine)." Apothecon Inc (2022):
  11. "Product Information. Gardasil (human papillomavirus vaccine)." Merck & Co., Inc (2006):
  12. "Product Information. Cervarix (human papillomavirus vaccine)." GlaxoSmithKline (2009):
  13. "Product Information. Prevnar 13 (pneumococcal 13-valent conjugate vaccine)." Apothecon Inc (2022):
  14. "Product Information. Gardasil 9 (human papillomavirus vaccine)." Merck & Co., Inc (2016):
View all 14 references

Cervarix drug interactions

There are 288 drug interactions with Cervarix (human papillomavirus vaccine).


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.